Group

N

Pre-treatment

After 12 weeks of treatment

Zoledronic acid

56

184.2268 ± 24.38384

102.9268 ± 14.78016

Denosumab

48

185.9036 ± 19.33483

94.6521 ± 10.43113

t

0.385

−3.246

P

0.701

0.002